健友股份 (603707.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

16.8x

EV/EBITDA

13.0x

Market Cap

CNY 12.57B

MomentumView details →

1D Return

−2.26%

YTD Return

−12.62%

RSI (14)

47.5

ValuationView details →

P/E (Fwd)

16.8x

EV/EBITDA

13.0x

Market Cap

CNY 12.57B

RSI (14)

47.5

MomentumView details →

1D Return

−2.26%

YTD Return

−12.62%

ProfitabilityView details →

Gross Margin

38.87%

Net Margin

14.52%

EBITDA Margin

23.40%

ROE (TTM)

8.38%

ROA (TTM)

5.48%

Asset Turnover

0.38x

GrowthView details →

Revenue YoY

+6.03%

EPS YoY

−17.45%

FCF YoY

+42.64%

Revenue CAGR 3Y

+2.44%

EPS CAGR 3Y

−18.70%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.06

EPS Surprise

−58.89%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.18

Avg Surprise (4Q)

−58.89%

Rev Surprise

−1.06%

Capital & dividendView details →

Debt/Equity

0.26x

Current Ratio

2.27x

Quick Ratio

1.40x

Div Yield

1.27%

Div Rate

CNY 0.10

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

4.03B

Net Income (TTM)

585.83M

Op. CF (TTM)

1.53B

Next earningsOct 26, 2026 →

Latest newsMore news →

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. received a drug registration certificate from the National Medical Products Administration for its propofol emulsion injection 20ml:200mg, marking the approval for marketing in China.60d ago

Similar companies

Elanco Animal Health IncorporatedELAN 浙江医药600216.SH Sunshine Lake Pharma Co., Ltd.06887.HK 国邦医药605507.SH Consun Pharmaceutical Group Limited01681.HK Ab&B Bio Tech Co Ltd.02627.HK Find similar companies →

Latest newsMore news →

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. received a drug registration certificate from the National Medical Products Administration for its propofol emulsion injection 20ml:200mg, marking the approval for marketing in China.60d ago